Europe — EMA
Palonosetron Reig Jofre
Palonosetron, the active ingredient in Palonosetron Reig Jofre, is a serotonin 5‑HT3 receptor antagonist presented as a sterile injectable solution for intravenous use.
Request sourcing
What is Palonosetron?
Palonosetron, the active ingredient in Palonosetron Reig Jofre, is a serotonin 5‑HT3 receptor antagonist presented as a sterile injectable solution for intravenous use. It is used to prevent nausea and vomiting associated with chemotherapy and postoperative settings in adult patients. GNH USA supplies Palonosetron Reig Jofre as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.
What is Palonosetron used for?
Palonosetron is a selective 5‑HT3 receptor antagonist indicated for the prevention of nausea and vomiting in several clinical pathways. - Chemotherapy‑induced nausea and vomiting (CINV): Provides long‑lasting protection against acute and delayed phases of CINV. - Post‑operative nausea and vomiting (PONV): Reduces the incidence of nausea and vomiting after surgical procedures. - Radiotherapy‑induced nausea and vomiting: Helps control nausea and vomiting associated with radiation treatment.
What are the side effects of Palonosetron?
Adverse reactions to palonosetron are generally mild to moderate, but clinicians monitor for both common and rare events.
Common Side Effects: - Headache: mild to moderate intensity. - Constipation: occasional bowel movement changes. - Fatigue: general tiredness without specific cause. - Diarrhoea: transient loose stools. - Dizziness: brief episodes of light‑headedness.
Serious or Rare Side Effects: - QT interval prolongation: cardiac rhythm changes detectable on ECG. - Severe hypersensitivity: rash, pruritus, angio‑edema, or anaphylaxis. - Serotonin syndrome: rare when combined with other serotonergic agents. - Cardiac arrhythmias: uncommon but potentially life‑threatening. - Neuro‑muscular blockade: extremely rare neuromuscular effects.
What precautions apply to Palonosetron?
Palonosetron should be used with careful clinical assessment and monitoring. - Cardiac monitoring: patients with known prolonged QT interval should be evaluated before use. - Concomitant serotonergic drugs: assess risk of serotonin syndrome when adding other agents. - Electrolyte abnormalities: correct potassium, magnesium, and calcium levels prior to administration. - Pregnancy and lactation: weigh the risk against the‑ benef benef benef benef benef - Renal ? - Store at below 25°C: keep in the original packaging, protect from moisture and light.
What does Palonosetron interact with?
Palijat
--- ---
ewline
... ...



